INTRODUCTION
============

Silent ischemia occurs in 20--40% of patients with stable and unstable coronary syndromes. Unfortunately, for some patients, their first clinical manifestation is when they go into sudden cardiac arrest. Coronary artery calcium (CAC) score has emerged as a robust predictor of future coronary events in these asymptomatic primary prevention populations.[@B1] This noninvasive technique has proven to be a reliable tool for estimating overall coronary plaque burden[@B2] and to generally correlate well with the severity of coronary artery stenosis (CAD).[@B2][@B3] However, in some cases, obstructive or even severe CAD has been detected in patients with zero or very low (\<10) calcium scores.[@B4][@B5] These false negative patients should be carefully monitored and may need prompt intervention to prevent the progression of acute coronary syndrome. We aimed to evaluate clinical key predictors of severe CAD in this population and sought to develop better prediction models for the detection of severe CAD combined with clinical risk factors.

MATERIALS AND METHODS
=====================

Study population and data collection
------------------------------------

The institutional review board of Myongji Hospital approved this study and waived the requirement for informed patient consent (IRB number: MJH-16-098). In this retrospective and observational study, from April 2011 to April 2016, we consecutively enrolled 3022 asymptomatic subjects who underwent coronary computed tomography angiography (CTA) with coronary calcium scan at the same time during health check-ups or outpatient clinics in Myongji Hospital. Among those populations, 1231 subjects with CAC scores of zero or less than 10 were enrolled. Males or females were excluded from the study if they were younger than 20 years or older than 80 years or had previous history of CAD, such as myocardial ischemia/infarction, percutaneous coronary intervention, or coronary artery bypass graft surgery. Poor quality CTA images were also excluded (n=55). Hence, a total of 1176 subjects were analyzed for CAD using CTA. Clinical risk factors, such as age, gender, body mass index (BMI), hypertension (HTN), type II diabetes mellitus (DM), dyslipidemia, lipid profile, and smoking status, were evaluated as predictors for severe CAD.

Measurement of CAC and CTA
--------------------------

For coronary calcium scan and CTA, we used a 64 multi-detector computed tomography scanner (Lightspeed Volume CT, GE Healthcare, Milwaukee, WI, USA). One hour prior to the CT scan, we administered 100 mg of atenolol to patients who had heart rates of more than 65 beats/min. Immediately before scanning, 0.6-mg sublingual nitroglycerin was given to all patients. Coronary calcium scan was performed before CTA scanning. The calcium scan parameters were as follows: prospective electrocardiogram-triggered at 70% of the R-R interval, 2.5-mm slice thickness, a gantry rotation time of 350 ms, a tube voltage of 120 kVp, and a tube current of 200--250 mA (depending on the patient\'s BMI). CAC score was calculated according to the Agatston method.[@B6] The analysis was performed using a commercially available external workstation (Advantage Windows, version 4.2, GE Healthcare, Milwaukee, WI, USA), as well as CAC scoring software (Smartscore 3.5, GE Healthcare, Milwaukee, WI, USA). Moderate and severe CAD were defined as having more than 50% or more than 70% stenosis in any of the major coronary arteries, respectively.

Statistical analysis
--------------------

Data are reported as mean±standard deviation for continuous variables and as counts with proportions (%) for categorical variables. Continuous variables were compared using an unpaired t-test for normally distributed variables or the Mann-Whitney U test for non-normally distributed variables. Categorical variables were examined by Pearson\'s chi-square or Fisher\'s exact test. Global chi-square analyses utilized logistic regressions and likelihood ratios tests. Univariable and multivariable odds ratios (ORs) estimates with 95% confidence intervals (95% CIs) were analyzed to evaluate predictors of moderate and severe CAD. Among univariate analysis, significant variables (*p* value\<0.05) were tested in multivariate analysis, except age and gender. Ten-fold cross-validated estimates of the area under the receiver operating characteristic curve (AUC) models were employed to evaluate the discrimination of severe CAD. The estimates were using the method proposed by DeLong, et al.[@B7] Statistical analyses were performed using MedCalc software (version 17.6; MedCalc Software, Mariakerke, Belgium).

RESULTS
=======

Among the 1176 subjects, 47.2% (n=555) were male, with a mean age of 56.5±12.3. The mean CAC was 0.8±2.1, and zero CAC was observed in 82.7% (n=972). Moderate (≥50%) CAD was present in 7.5% (n=88) and severe (≥70%) CAD in 3.3% (n=39) of the total population on CTA. Moderate (14.7% vs. 6.0%, *p*\<0.001) and severe CAD (6.4% vs. 2.7%, *p*=0.014) were found to be two- to three-fold higher in the non-zero (1 to 9) CAC group than in the zero CAC group ([Fig. 1](#F1){ref-type="fig"}). We found that 37.3% (n=439) of the total population had HTN, 12.1% (n=142) had DM, and 41.9% (n=493) presented with dyslipidemia. Statin use status was recorded in 30.0% (n=459), and 20.0% (n= 235) were current smokers.

Moderate stenosis (≥50%) CAD by CTA
-----------------------------------

When divided into two groups, the group with ≥50% stenosis by CTA (the obstructive CAD group) was older (61.6±10.7 vs. 56.1±12.3, *p*\<0.001), was male predominant (62.5% vs. 46.0%, *p*=0.004), had more DM (21.6% vs. 11.3%, *p*=0.007), had lower high density lipoprotein (HDL) (47.0±14.4 vs. 52.1±14.4, *p*= 0.002), and had fewer subjects with zero CAC (34.1% vs. 16.0%, *p*\<0.001), compared to the non-obstructive CAD group ([Table 1](#T1){ref-type="table"}). In univariate analysis, age (OR 1.04, 95% CI 1.02--1.06, *p*\<0.001), male (OR 1.96, 1.25--3.07), DM (OR 2.16, 1.26--3.71, *p*=0.005), low HDL cholesterol (OR 0.97, 0.96--0.99, *p*= 0.002), current smoking status (OR 3.43, 2.19--5.39, *p*\<0.001), and non-zero CAC (OR 2.72, 1.70--4.35, *p*\<0.001) were associated with obstructive CAD ([Table 2](#T2){ref-type="table"}). In multivariate analysis, age (OR 1.04, 95% CI 1.02--1.07, *p*\<0.001), current smoking status (OR 3.12, 1.82--5.34, *p*\<0.001), and non-zero CAC (OR 1.80, 1.08--3.00, *p*=0.024) were significantly associated with obstructive CAD ([Table 2](#T2){ref-type="table"}).

Severe stenosis (≥70%) CAD by CTA
---------------------------------

The severe CAD group had a stronger likelihood of being older (62.4±11.2 vs. 56.3±12.3, *p*=0.002) with lower HDL (42.9±9.2 vs. 52.0±14.5, *p*\<0.001) than the non-severe CAD group ([Table 1](#T1){ref-type="table"}). Univariate analysis showed age (OR 1.04, 95% CI 1.01--1.07, *p*=0.003), DM (OR 2.26, 1.05--4.87, *p*=0.037), low HDL cholesterol (OR 0.95, 0.92--0.97, *p*\<0.001), current smoking status (OR 2.92, 95% CI 1.51--5.61, *p*=0.001), and non-zero CAC (1--9) score (OR 2.48, 95% CI 1.25--4.91, *p*=0.009) to be significantly associated with severe CAD ([Table 3](#T3){ref-type="table"}). However, only age (OR 1.05, 95% CI 1.02--1.08, *p*=0.003), low HDL (OR 0.96, 95% CI 0.93--0.99, *p*=0.003), and current smoking status (OR 2.45, 95% CI 1.14--5.30, *p*=0.022) were found to be significantly associated with severe CAD in multivariate analysis ([Table 3](#T3){ref-type="table"}). Improvement of discrimination power for predicting severe CAD was observed when smoking and HDL cholesterol were serially added into the age model: the AUC value was higher in the "Age+Smoking+HDL cholesterol" model when compared to the "Age+Smoking" model (AUC 0.77, 95% CI 0.74--0.80 vs. AUC 0.70, 95% CI 0.67--0.73, *p*=0.020) ([Fig. 2](#F2){ref-type="fig"}).

Zero CAC analysis
-----------------

Among the 972 people in the zero CAC group, 6.0% (n=58) had obstructive CAD and 2.7% (n=26) had severe CAD ([Fig. 1](#F1){ref-type="fig"}, [Tables 4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}). Age, males, DM, low HDL cholesterol, and current smoking status were associated with severe CAD in univariate analysis ([Table 5](#T5){ref-type="table"}). When adjusted for these variables, age (OR 1.06, 95% CI 1.02--1.10, *p*=0.002), low HDL cholesterol (OR 0.96, 95% CI 0.93--1.00, *p*=0.003), and current smoking status (OR 3.07, 95% CI 1.17--8.08, *p*=0.023) were significant independent predictors for severe CAD in multivariate analysis ([Table 5](#T5){ref-type="table"}), which was in line with the less than CAC analyses. In this analysis, current smoking status was a consistent predictor for obstructive CAD (OR 3.82, 95% CI 1.95--7.49, *p*\<0.001) and severe CAD. However, low HDL cholesterol was a significant predictor for severe CAD, while it was not for obstructive CAD. The suggested cut-off value of low HDL cholesterol level to predict the presence of severe CAD was 46 mg/dL, with a sensitivity of 74.4% and a specificity of 61.9%.

DISCUSSION
==========

Individuals with extremely low or even zero CAC are usually considered as free of significant CAD, especially those who are asymptomatic. Infrequently, however, serious CAD is observed in this population, which is a concern since a false negative study might cause optimal treatment times to be missed. In this study, we sought to find any clinical clues for prediction of such serious CAD in these falsely diagnosed populations by evaluating clinical CAD risk factors to identify any additional associations with moderate or severe CAD by CTA. We found that extremely small calcification, such as a CAC score of 1 to 9, itself was associated with moderate CAD, but not independently associated with severe CAD, compared with zero CAC. Age, current smoking status, and extremely small calcification (CAC 1--9) were independently associated with moderate CAD. In addition, age, low HDL cholesterol, and current smoking status were shown to be independently associated with severe CAD. We also discovered that current smoking status was a significant predictor of moderate and severe CAD among the less than 10 CAC and even in the zero CAC population. Interestingly enough, low HDL cholesterol was only a significant predictor of severe CAD, not moderate CAD, among the less than 10 CAC or even in the zero CAC group. Moreover, a cut-off value of 46 mg/dL of HDL cholesterol showed a sensitivity of 74.4% and specificity of 61.9% for the prediction of severe CAD.

Coronary artery calcification indicates the presence of active inflammation or the stabilization of atherosclerotic plaque, and the total amount of coronary artery calcification is strongly related to the total coronary plaque burden.[@B8][@B9][@B10] Accordingly, coronary calcium scan has been established as a robust noninvasive CAD screening method, especially in the primary prevention population. Recently, several studies have demonstrated that CAC is a far superior discriminatory marker than global cardiovascular clinical risk factors.[@B11][@B12][@B13] Many studies have also shown that CAC is directly proportional to the severity of CAD.[@B2][@B13] However, severe CAD has been found in a considerable number of patients with low CAC.[@B4][@B5][@B14] The incidences of significant CAD in patients with zero or very low CAC have varied in previous reports.[@B15] Gottlieb, et al.[@B5] reported that 19% had obstructive CAD (≥50%) among the symptomatic zero CAC population (n=291). However, Rubinshtein, et al.[@B16] and Koulaouzidis, et al.[@B15] reported incidences of 7% (n=231) and 0.9% (n=447), respectively, within the same symptomatic zero CAC population. As for the asymptomatic population, Choi, et al.[@B4] and Lee, et al.[@B17] reported incidences of 5% (n=1000) and 0.7% (n=6531), respectively. In our study, obstructive CAD and severe CAD were identified in 6.0% and 2.7% of 972 asymptomatic subjects with zero CAC, respectively. In subjects with a less than 10 CAC score (n=1176), 7.5% were found to have obstructive CAD and 3.3% severe CAD. Hence, as with the symptomatic population, significant CAD cannot be ruled out in asymptomatic individuals with zero CAC.

We found that, among traditional CAD risk factors, current smoking status was the strongest risk factor for obstructive CAD and severe CAD patients, while low HDL cholesterol was the strongest predictor associated with severe CAD. Smoking is an established CAD risk factor.[@B18] It is also known that smoking leads to a decreased HDL cholesterol level through the dysfunction of lipid transport enzymes.[@B19] In this study, low HDL and smoking seemed to be related with and have an effect on the development of coronary atherosclerosis. In addition, smoking can cause endothelial dysfunction, enhance platelet aggregation, and impair fibrinolysis.[@B18] These alterations may be responsible for the increased prevalence and severity of thrombotic cardiovascular events in cigarette smokers.[@B20]

There are several limitations to our study. First, the number of patients was relatively small. In addition, it was limited to a single center study. It is necessary to follow up with a larger number of patients from a multi-center study to confirm our results. Second, the study was a retrospective study. Thus, similar to other retrospective studies, self-referral bias was a significant limitation. Third, various ethnicities were not considered in this study. Finally, plaque characteristics and prognostic information were not included in this analysis due to its cross-sectional study design. Long-term follow up of prognoses with plaque characteristics might be needed to ascertain further clinical implications.

In conclusion, our analysis demonstrated that smoking is most strongly correlated with obstructive or severe CAD, even in asymptomatic individuals with extremely low CAC scores. Low HDL cholesterol levels were also found to be a powerful predictor of severe CAD in the same subjects. These factors might be useful indicators worthy of consideration when screening for CAD in asymptomatic people.
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###### Baseline Patient Characteristics according to CAD Severity
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                            CAC≤10 (n=1176)                                                      
  ------------------------- ----------------- ------------- --------- ------------ ------------- ---------
  Age (yr)                  61.6±10.7         56.1±12.3     \<0.001   62.4±11.2    56.3±12.3     0.002
  Male (n, %)               55 (62.5)         500 (46.0)    0.004     24 (61.5)    531 (46.7)    0.10
  BMI                       24.3±3.3          24.8±3.7      0.22      23.7±3.2     24.8±3.7      0.056
  DM (n, %)                 19 (21.6)         123 (11.3)    0.007     9 (23.1)     133 (11.7)    0.058
  HTN (n, %)                39 (44.3)         400 (36.8)    0.20      14 (35.9)    425 (37.4)    0.98
  Dyslipidemia (n, %)       32 (36.4)         461 (42.4)    0.32      11 (28.2)    482 (42.4)    0.11
  Statin use (n, %)         31 (35.3)         428 (39.3)    0.52      11 (28.2)    448 (39.4)    0.21
  LDL cholesterol (mg/dL)   104.3±37.3        109.7±35.2    0.18      105.2±41.9   109.4±35.2    0.47
  HDL cholesterol (mg/dL)   47.0±14.4         52.1±14.4     0.002     42.9±9.2     52.0±14.5     \<0.001
  TG (mg/dL)                145.1±85.6        141.7±114.4   0.79      144.4±68.5   141.9±113.6   0.89
  Creatinine (mg/dL)        1.0±0.3           1.0±0.7       0.27      1.1±0.3      1.0±0.7       0.25
  Current smoking (n, %)    38 (43.2)         197 (18.1)    \<0.001   16 (41.0)    219 (19.3)    0.002
  CAC score 1--9 (n, %)     30 (34.1)         174 (16.0)    \<0.001   13 (33.3)    191 (16.8)    0.014
  LM disease                2                 \-            \-        0            \-            \-
  CAD 1VD                   53                \-            \-        23           \-            \-
  CAD 2VD                   31                \-            \-        12           \-            \-
  CAD 3VD                   4                 \-            \-        4            \-            \-
  PCI                       23                \-            \-        22           \-            \-

CAD, coronary artery disease; CAC, coronary artery calcium; BMI, body mass index; DM, diabetes mellitus; HTN, hypertension; LDL, low density lipoprotein; HDL, high density lipoprotein; TG, triglyceride; LM, left main; VD, vessel disease; PCI, percutaneous coronary intervention.

Values are presented as mean±standard or n (%) deviation unless otherwise indicated.

###### Univariate and Multivariate Aanalysis for Detecting Moderate (≥50% stenosis) CAD
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                    CAC≤10 (n=1176)                                              
  ----------------- ----------------- ------------ --------- ------ ------------ ---------
  Age               1.04              1.02--1.06   \<0.001   1.04   1.02--1.07   \<0.001
  Male              1.96              1.25--3.07   0.003     1.67   0.96--2.91   0.072
  BMI               0.96              0.90--1.02   0.22      \-     \-           \-
  DM                2.16              1.26--3.71   0.005     1.24   0.69--2.24   0.48
  HTN               1.37              0.88--2.12   0.16      \-     \-           \-
  Dyslipidemia      0.78              0.50--1.22   0.27      \-     \-           \-
  Statin use        0.84              0.53--1.32   0.45      \-     \-           \-
  LDL cholesterol   1.00              0.99--1.00   0.18      \-     \-           \-
  HDL cholesterol   0.97              0.96--0.99   0.002     0.99   0.97--1.01   0.30
  TG                1.00              0.99--1.00   0.79      \-     \-           \-
  Creatinine        1.12              0.90--1.40   0.30      \-     \-           \-
  Current smoking   3.43              2.19--5.39   \<0.001   3.12   1.82--5.34   \<0.001
  CAC score 1--9    2.72              1.70--4.35   \<0.001   1.80   1.08--3.00   0.024

CAD, coronary artery disease; CAC, coronary artery calcium; CI, confidence interval; BMI, body mass index; DM, diabetes mellitus; HTN, hypertension; LDL, low density lipoprotein; HDL, high density lipoprotein; TG, triglyceride.

###### Univariate and Multivariate Analysis for Detecting Severe (≥70% Stenosis) CAD
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                    CAC≤10 (n=1176)                                              
  ----------------- ----------------- ------------ --------- ------ ------------ -------
  Age               1.04              1.01--1.07   0.003     1.05   1.02--1.08   0.003
  Male              1.83              0.95--3.52   0.07      1.50   0.68--3.32   0.32
  BMI               0.91              0.82--1.00   0.054     \-     \-           \-
  DM                2.26              1.05--4.87   0.037     1.24   0.55--2.78   0.60
  HTN               0.94              0.48--1.82   0.85      \-     \-           \-
  Dyslipidemia      0.53              0.26--1.08   0.082     \-     \-           \-
  Statin use        0.60              0.30--1.23   0.163     \-     \-           \-
  LDL cholesterol   1.00              0.99--1.01   0.47      \-     \-           \-
  HDL cholesterol   0.95              0.92--0.97   \<0.001   0.96   0.93--0.99   0.003
  TG                1.00              1.00--1.00   0.89      \-     \-           \-
  Creatinine        1.15              0.89--1.50   0.29      \-     \-           \-
  Current smoking   2.92              1.51--5.61   0.001     2.45   1.14--5.30   0.022
  CAC score 1--9    2.48              1.25--4.91   0.009     1.50   0.73--3.11   0.27

CAD, coronary artery disease; CAC, coronary artery calcium; CI, confidence interval; BMI, body mass index; DM, diabetes mellitus; HTN, hypertension; LDL, low density lipoprotein; HDL, high density lipoprotein; TG, triglyceride.

###### Univariate and Multivariate Analysis for Detecting Moderate (≥50% Stenosis) CAD in the Zero CAC Population
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                    CAC=0 (n=972)                                              
  ----------------- --------------- ------------ --------- ------ ------------ ---------
  Age               1.04            1.02--1.07   \<0.001   1.06   1.03--1.09   \<0.001
  Male              1.86            1.08--3.20   0.023     1.68   0.84--3.37   0.15
  BMI               0.99            0.92--1.07   0.78      \-     \-           \-
  DM                2.91            1.54--5.52   0.001     1.84   0.91--3.73   0.090
  HTN               1.71            1.00--2.93   0.049     0.86   0.46--1.61   0.63
  Dyslipidemia      0.63            0.35--1.12   0.12      \-     \-           \-
  Statin use        0.72            0.40--1.28   0.26      \-     \-           \-
  LDL cholesterol   1.00            0.99--1.01   0.63      \-     \-           \-
  HDL cholesterol   0.97            0.95--0.99   0.011     0.99   0.97--1.01   0.25
  TG                1.00            1.00--1.00   0.79      \-     \-           \-
  Creatinine        1.13            0.88--1.44   0.33      \-     \-           \-
  Current smoking   3.86            2.24--6.65   \<0.001   3.82   1.95--7.49   \<0.001

CAD, coronary artery disease; CAC, coronary artery calcium; CI, confidence interval; BMI, body mass index; DM, diabetes mellitus; HTN, hypertension; LDL, low density lipoprotein; HDL, high density lipoprotein; TG, triglyceride.

###### Univariate and Multivariate Analysis for Detecting Severe (≥70% Stenosis) CAD in the Zero CAC Population
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                    CAC=0 (n=972)                                            
  ----------------- --------------- ------------ ------- ------ ------------ -------
  Age               1.05            1.02--1.09   0.004   1.06   1.02--1.10   0.002
  Male              1.63            0.74--3.58   0.22    1.43   0.53--3.88   0.48
  BMI               0.95            0.85--1.07   0.38    \-     \-           \-
  DM                3.22            1.32--7.87   0.010   1.71   0.67--4.35   0.26
  HTN               1.08            0.48--2.45   0.85    \-     \-           \-
  Dyslipidemia      0.38            0.14--1.01   0.051   \-     \-           \-
  Statin use        0.41            0.15--1.10   0.077   \-     \-           \-
  LDL cholesterol   1.00            0.99--1.01   0.85    \-     \-           \-
  HDL cholesterol   0.95            0.92--0.98   0.001   0.96   0.93--1.00   0.028
  TG                1.00            1.00--1.00   0.48    \-     \-           \-
  Creatinine        1.15            0.85--1.55   0.37    \-     \-           \-
  Current Smoking   3.25            1.47--7.21   0.004   3.07   1.17--8.08   0.023

CAD, coronary artery disease; CAC, coronary artery calcium; CI, confidence interval; BMI, body mass index; DM, diabetes mellitus; HTN, hypertension; LDL, low density lipoprotein; HDL, high density lipoprotein; TG, triglyceride.
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